As a clinician-scientist, Dr. Elsaid has active research programs in translational pharmacology and practice-based research.
Dr. Elsaid’s research in translational pharmacology focuses on developing interventions that address unmet clinical need in the area of musculoskeletal diseases, specifically PTOA and Gout. As such, Dr. Elsaid’s lab is focused on elucidating the mechanisms that contribute to OA development and acute gout exacerbations, evaluating the suitability of various pharmacologic agents with diverse mechanisms of actions as disease modifying agents and investigating biomarkers indicative of OA disease onset and progression. Additionally, Dr. Elsaid works on developing novel approaches to enhance joint residence of intra-articularly-administered biologics. Below are some recent publications in this area of research:
